We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

MedImmune V. Genentech And Licensee Estoppel

Law360 (February 23, 2007, 12:00 AM EST) -- As noted in the February 7, 2007 edition of IP Law360 (“A Contrarian View Of MedImmune V. Genentech”), the Supreme Court’s MedImmune decision addressed only jurisdictional issues, and did not hold as to whether the doctrine of licensee estoppel, or the Lear doctrine, apply to a so-called non-repudiating (i.e., non-breaching) licensee.

In fact, it appears more likely than not that MedImmune may have been much ado about nothing regarding licensee estoppel and the non-repudiating licensee. Once the case is heard on the merits, the licensee could...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.